Clinical Trial Update: SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update explores combining SBRT with Adbelimumab and Apatinib for perioperative and conversion therapy in hepatocellular carcinoma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Adbelimumab
• Apatinib (apatinib)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Hepatocellular Carcinoma, SBRT | Phase 2 | Status: NOT_YET_RECRUITING